Literature DB >> 25209683

[Measures to improve the health situation of patients with rare diseases in Germany. A comparison with the National Action Plan].

M Frank1, D Eidt-Koch, I Aumann, A Reimann, T O F Wagner, J-M Graf von der Schulenburg.   

Abstract

BACKGROUND: Approximately 4 million patients with a rare disease live in Germany. The medical care of these patients is problematic because of the rarity and heterogeneity of different clinical pictures. The Federal Ministry of Health has therefore published a research report on "Measures to improve the health situation of people with rare diseases in Germany" in 2009.
OBJECTIVE: The aim of this paper is to present the main recommendations of this research report and relate it to current developments in the field of medical care for people with rare diseases.
METHODOLOGY: The care situation of patients with rare diseases was determined using questionnaires, expert interviews and focus group discussions with representatives of patients, service providers and stakeholders from the health institutions.
RESULTS: The main range of actions that have been identified in the research report were centre and network formation, specialized forms of medical care, diagnosis and treatment, information and experience exchange, performance fees and reimbursement of the costs, guidelines and patient pathways, the research, the implementation of a National Action Alliance and the development of a National Action Plan. DISCUSSION: In March 2010 a National Action League for People with Rare Diseases (NAMSE) was founded. The NAMSE created a national plan of action for people with rare diseases for improving medical care in the field of rare diseases which was approved by the Federal Government in August 2013. Thus, two important areas of the research report have already been implemented. In a comparison of the areas of activity of the research report with those of the National Action Plan it becomes clear that priorities will be in the context of health services research in rare diseases, for example the introduction of centres of reference for rare diseases, measures to accelerate the diagnostic process and the promotion of research and information management in the future.

Entities:  

Mesh:

Year:  2014        PMID: 25209683     DOI: 10.1007/s00103-014-2040-2

Source DB:  PubMed          Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz        ISSN: 1436-9990            Impact factor:   1.513


  6 in total

1.  Unmet Needs of Parents of Children with Urea Cycle Disorders.

Authors:  Mara Scharping; Heiko Brennenstuhl; Sven F Garbade; Beate Wild; Roland Posset; Matthias Zielonka; Stefan Kölker; Markus W Haun; Thomas Opladen
Journal:  Children (Basel)       Date:  2022-05-12

2.  How to design a registry for undiagnosed patients in the framework of rare disease diagnosis: suggestions on software, data set and coding system.

Authors:  Alexandra Berger; Anne-Kathrin Rustemeier; Jens Göbel; Dennis Kadioglu; Vanessa Britz; Katharina Schubert; Klaus Mohnike; Holger Storf; Thomas O F Wagner
Journal:  Orphanet J Rare Dis       Date:  2021-05-01       Impact factor: 4.303

3.  Rare pediatric diseases and pathways to psychosocial care: a qualitative interview study with professional experts working with affected families in Germany.

Authors:  Stefanie Witt; Kaja Kristensen; Silke Wiegand-Grefe; Johannes Boettcher; Janika Bloemeke; Christina Wingartz; Monika Bullinger; Julia Quitmann
Journal:  Orphanet J Rare Dis       Date:  2021-11-27       Impact factor: 4.123

4.  Acceptance and commitment therapy meets peer-support. Development of a supportive self-care intervention for patients with rare diseases: a multistage development process.

Authors:  Miriam K Depping; Natalie Uhlenbusch; Bernd Löwe
Journal:  BMJ Open       Date:  2021-07-02       Impact factor: 2.692

5.  The health and life path of rare disease patients: results of the 2015 French barometer.

Authors:  Thomas Heuyer; Sonia Pavan; Christine Vicard
Journal:  Patient Relat Outcome Meas       Date:  2017-09-13

6.  Evaluation of two family-based intervention programs for children affected by rare disease and their families - research network (CARE-FAM-NET): study protocol for a rater-blinded, randomized, controlled, multicenter trial in a 2x2 factorial design.

Authors:  Johannes Boettcher; Bonnie Filter; Jonas Denecke; Amra Hot; Anne Daubmann; Antonia Zapf; Karl Wegscheider; Jan Zeidler; J-Matthias Graf von der Schulenburg; Monika Bullinger; Miriam Rassenhofer; Michael Schulte-Markwort; Silke Wiegand-Grefe
Journal:  BMC Fam Pract       Date:  2020-11-20       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.